- Home
- Publications
- Publication Search
- Publication Details
Title
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 6, Pages 1412
Publisher
MDPI AG
Online
2021-03-19
DOI
10.3390/cancers13061412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians
- (2021) Daniel Geh et al. Hepatobiliary Surgery and Nutrition
- PD-1 gene rs10204525 and rs7421861 polymorphisms are associated with increased risk and clinical features of esophageal cancer in a Chinese Han population
- (2020) Bao Zang et al. Aging-US
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort
- (2020) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
- (2020) Matthias Pinter et al. GUT
- A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- CD44, IL-33, and ST2 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility in the Chinese Population
- (2020) Xiaolan Pan et al. Biomed Research International
- A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
- (2019) Rasha El Sharkawy et al. Scientific Reports
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk
- (2019) Chunhong Huang et al. MEDICINE
- Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
- (2019) Mohammad Hashemi et al. Cancers
- Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis
- (2019) Shan Tang et al. BMC CANCER
- Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
- (2019) Kun Huang et al. BMC Medical Genetics
- Report of the 20th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan
- (2019) Masatoshi Kudo et al. HEPATOLOGY RESEARCH
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- PD-1 3’untranslated region polymorphism is associated with spontaneous clearance of Hepatitis B virus infection
- (2018) Hajar Chihab et al. JOURNAL OF MEDICAL VIROLOGY
- Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes Mellitus, 1988–2015
- (2018) Yiling J. Cheng et al. DIABETES CARE
- Quantifying the regulatory effect size ofcis-acting genetic variation using allelic fold change
- (2017) Pejman Mohammadi et al. GENOME RESEARCH
- PD-1 and cancer: molecular mechanisms and polymorphisms
- (2017) Arash Salmaninejad et al. IMMUNOGENETICS
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Annotation-free quantification of RNA splicing using LeafCutter
- (2017) Yang I. Li et al. NATURE GENETICS
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases
- (2017) Amal A. Mohamed et al. Journal of Advanced Research
- PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis
- (2016) Edmondo Falleti et al. DIGESTIVE AND LIVER DISEASE
- Genetic and Epigenetic Regulation of PD-1 Expression
- (2016) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies
- (2016) Wenjing Dong et al. PLoS One
- The Genotype-Tissue Expression (GTEx) Project
- (2015) Latarsha J. Carithers et al. BIOPRESERVATION AND BIOBANKING
- GTEx pilot quantifies eQTL variation across tissues and individuals
- (2015) Orli G. Bahcall NATURE REVIEWS GENETICS
- The Genotype-Tissue Expression (GTEx) Project
- (2015) Latarsha J. Carithers et al. Biopreservation and Biobanking
- The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
- (2014) Matthew M. Staron et al. IMMUNITY
- PD-1 mRNA expression is associated with clinical and viral profile and PD1 3′-untranslated region polymorphism in patients with chronic HBV infection
- (2014) Guoyu Zhang et al. IMMUNOLOGY LETTERS
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- (2014) Y.-L. Liu et al. JOURNAL OF HEPATOLOGY
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- (2014) Yang-Lin Liu et al. Nature Communications
- CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
- (2014) Ying-Erh Chou et al. Biomed Research International
- NAFLD leads to liver cancer: Do we have sufficient evidence?
- (2013) Xiao-Yan Duan et al. CANCER LETTERS
- Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection
- (2013) Zhu Li et al. INFECTION GENETICS AND EVOLUTION
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Transcriptome and genome sequencing uncovers functional variation in humans
- (2013) Tuuli Lappalainen et al. NATURE
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma
- (2011) Vinod Kumar et al. NATURE GENETICS
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Meta-analysis and imputation refines the association of 15q25 with smoking quantity
- (2010) Jason Z Liu et al. NATURE GENETICS
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype Data
- (2008) Frank Dudbridge HUMAN HEREDITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More